🔎 Trials Near Me

Home › Blood Cancers › Colorado › Denver

Blood Cancers clinical trials in Denver, CO

9 studies for Blood Cancers are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

RecruitingPhase 2
  • Colorado Blood Cancer Institute ( Site 2726), Denver
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT04728893

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • AdventHealth Porter, Denver
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

RecruitingPhase 1
  • Colorado Blood Cancer Institute, Denver
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT06001788

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

RecruitingPhase 3
  • Colorado Blood Cancer Institute, Denver
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT07007312

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

RecruitingPhase 1
  • Colorado Blood Cancer Institute, Denver
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT06823167

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecruitingObservational study
  • Presbyterian St. Luke's/Colorado Blood Cancer Institute, Denver
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

RecruitingPhase 1
  • Colorado Blood Cancer Institute, Denver
Ages 18 and older · All sexes · Updated Mar 13, 2026 · NCT05735184

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RecruitingPhase 1
  • Children's Hospital Colorado, Denver
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770

Blood Cancers trials in other cities

Other studies in Denver

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.